Your session is about to expire
← Back to Search
Carbonated Water for Orthostatic Hypotension
N/A
Recruiting
Led By Victoria E Claydon, PhD
Research Sponsored by Simon Fraser University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Must not have
History of cardiovascular disease
History of neurological disease
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 0-50 minutes
Awards & highlights
No Placebo-Only Group
Summary
This trial investigates if carbonated water can help people maintain normal blood pressure when standing, so they don't faint or feel dizzy.
Who is the study for?
This trial is for healthy, English-speaking individuals without a history of cardiovascular or neurological diseases, not pregnant, and who haven't fainted more than once in the past six months. It's designed to see if carbonated water helps people maintain blood pressure when standing up.
What is being tested?
The study tests whether drinking 500mL of carbonated water improves orthostatic tolerance—the ability to keep blood pressure stable when standing—compared to the same amount of still water. A smaller volume (50mL) of still water serves as an additional control.
What are the potential side effects?
There are no significant side effects expected from consuming carbonated or still water in this trial; however, some individuals might experience mild gastrointestinal discomfort due to gas from the carbonation.
Eligibility Criteria
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have a history of heart disease.
Select...
I have a history of a neurological condition.
Select...
I have fainted at least twice in the last 6 months.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 0-50 minutes
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0-50 minutes
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Orthostatic tolerance
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
6Treatment groups
Experimental Treatment
Group I: 50mL still water first, then 500mL still water, then 500 mL carbonated waterExperimental Treatment3 Interventions
Participants will undergo this test on three separate days. On each day participants will be asked to drink a glass of water: either a 50mL drink of still water (control condition), a 500mL drink of still (non-carbonated) water, or a 500mL drink of carbonated water. In this arm of the study, participants will receive 50mL still water on the first test day, 500mL carbonated water on the second test day, then 500mL carbonated water on the third day.
Group II: 50mL still water first, then 500mL carbonated water, then 500 mL still waterExperimental Treatment3 Interventions
Participants will undergo this test on three separate days. On each day participants will be asked to drink a glass of water: either a 50mL drink of still water (control condition), a 500mL drink of still (non-carbonated) water, or a 500mL drink of carbonated water. In this arm of the study, participants will receive 50mL still water on the first test day, 500mL still water on the second test day, then 500mL still water on the third day.
Group III: 500mL still water first, then 50mL still water, then 500 mL carbonated waterExperimental Treatment3 Interventions
Participants will undergo this test on three separate days. On each day participants will be asked to drink a glass of water: either a 50mL drink of still water (control condition), a 500mL drink of still (non-carbonated) water, or a 500mL drink of carbonated water. In this arm of the study, participants will receive 500mL still water on the first test day, 50mL still water on the second test day, then 500mL carbonated water on the third day.
Group IV: 500mL still water first, then 500 mL carbonated water, then 50mL still waterExperimental Treatment3 Interventions
Participants will undergo this test on three separate days. On each day participants will be asked to drink a glass of water: either a 50mL drink of still water (control condition), a 500mL drink of still (non-carbonated) water, or a 500mL drink of carbonated water. In this arm of the study, participants will receive 500mL still water on the first test day, 500mL carbonated water on the second test day, then 50mL still water on the third day.
Group V: 500mL carbonated water first, then 50mL of still water, then 500mL of still waterExperimental Treatment3 Interventions
Participants will undergo this test on three separate days. On each day participants will be asked to drink a glass of water: either a 50mL drink of still water (control condition), a 500mL drink of still (non-carbonated) water, or a 500mL drink of carbonated water. In this arm of the study, participants will receive 500mL carbonated water on the first test day, 50mL still water on the second test day, then 500mL still water on the third day.
Group VI: 500mL carbonated water first, then 500mL of still water, then 50mL of still waterExperimental Treatment3 Interventions
Participants will undergo this test on three separate days. On each day participants will be asked to drink a glass of water: either a 50mL drink of still water (control condition), a 500mL drink of still (non-carbonated) water, or a 500mL drink of carbonated water. In this arm of the study, participants will receive 500mL carbonated water on the first test day, 500mL still water on the second test day, then 50mL still water on the third day.
Find a Location
Who is running the clinical trial?
Simon Fraser UniversityLead Sponsor
57 Previous Clinical Trials
10,663 Total Patients Enrolled
Victoria E Claydon, PhDPrincipal InvestigatorProfessor, Biomedical Physiology and Kinesiology
3 Previous Clinical Trials
63 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have a history of heart disease.I have a history of a neurological condition.This criterion means that the participant should be in good health with no major medical conditions.I have fainted at least twice in the last 6 months.
Research Study Groups:
This trial has the following groups:- Group 1: 500mL carbonated water first, then 500mL of still water, then 50mL of still water
- Group 2: 50mL still water first, then 500mL carbonated water, then 500 mL still water
- Group 3: 500mL still water first, then 500 mL carbonated water, then 50mL still water
- Group 4: 500mL carbonated water first, then 50mL of still water, then 500mL of still water
- Group 5: 500mL still water first, then 50mL still water, then 500 mL carbonated water
- Group 6: 50mL still water first, then 500mL still water, then 500 mL carbonated water
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.